The process of stem cell storage requires several important factors. Before storing, stem cells must be tested for viability and infectious diseases. Besides testing for infectious diseases, a cord blood bank must have a quality assurance system and transportation assurance to ensure the stem cells’ safety. Keeping your stem cells in the correct place is crucial for viability and eventual use. However, storing them in an inappropriate place can lead to various negative outcomes, so it is important to take extra precautions when storing them.
Transfer of authority:
Among the legal and ethical issues involved in adult stem cell preservation is who will own the stem cells and how they will be used in the future. Concerns about informed consent, donor capacity, and non-payment also play. The public’s perception of trust in a biobank is critical to its legitimacy and its commitment to serving patients. The following guidelines may help an organization protect its biosamples and ensure transparency and accountability.
Cost of storing stem cells:
Storage of stem cells requires significant capital and a high fee. For private blood banks, the initial fee is typically Dh1, 000-2,000 and annual storage fees are often more than Dh 100. Many health insurance policies do not cover the cost of storing stem cells. Some private blood banks offer free storage if a family requires stem cells immediately. But even these costs can be prohibitive for many families. For these reasons, many choose to store their stem cells privately.
Quality control system:
To ensure the safety of the stem cells and guarantee the quality of their final products, the stem cell industry should have a quality control system before storing them. A quality control system should be in place to monitor the substances and cells used in the manufacturing process. The quality of stem cells should be reflected in the quality of the whole process, which is why QT must be carried out at various key stages and the end of the manufacturing process.
Developing a quality control system is essential to the successful development of stem cell-based medicinal products (SCMPs). The quality control system must include technologies, reference materials, guidelines and the associated management system. This system must adhere to the requirements of regulations throughout the entire product’s lifetime. Unfortunately, the global stem cell industry lacks an effective quality control system. This lack of quality control technologies prevents accurate biological efficacy and safety assessment.